Xcellsyz Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Xcellsyz General Information

Description

Developer of drugs for the treatment of diabetes and obesity. The company is using human cell-based systems biology to discover new drugs to treat metabolic diseases such as diabetes and obesity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Primary Office
  • Bio Science Centre
  • Times Square
  • Newcastle upon Tyne NE1 4EP
  • England, United Kingdom
+44 0191 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xcellsyz Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Dec-2004 00.000 Completed Product Development
3. Grant 31-Oct-2003 00000 00.000 Completed
2. Early Stage VC (Series A) 03-Jul-2003 $2.83M $3.29M Completed Product Development
1. Seed Round $459K $459K Completed
To view Xcellsyz’s complete valuation and funding history, request access »

Xcellsyz Executive Team (2)

Name Title Board Seat Contact Info
Peter Shepherd Ph.D Co-Founder, Chief Executive Officer & Chief Scientific Officer
Brad Hoy Chief Executive Officer
To view Xcellsyz’s complete executive team members history, request access »

Xcellsyz Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Barcelona Empren Venture Capital Minority 000 0000 000000 0
Bloomsbury Bioseed Fund Venture Capital Minority 000 0000 000000 0
ITX Corporation Corporation Minority 000 0000 000000 0
NEL Fund Managers Asset Manager Minority 000 0000 000000 0
To view Xcellsyz’s complete investors history, request access »